Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 354,349 | 24,957 |
| TOTAL | $357,103 | $25,306 |
| Non-Current Assets | ||
| PPE Net | 591 | 323 |
| Investments And Advances | 100 | 100 |
| Other Non-Current Assets | 440 | 195 |
| TOTAL | $1,131 | $618 |
| Total Assets | $358,234 | $25,924 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 6,000 | 6,000 |
| Accounts payable and accrued liabilities | 1,996 | 1,866 |
| Accrued Expenses | 11,751 | 7,938 |
| TOTAL | $27,775 | $58,168 |
| Non-Current Liabilities | ||
| Long Term Debt | 2,502 | 8,201 |
| Deferred Revenues | 7,826 | 3,313 |
| Other Non-Current Liabilities | 156 | 132,951 |
| TOTAL | $7,332 | $141,152 |
| Total Liabilities | $35,107 | $199,320 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 35,850 | N/A |
| Retained earnings | -252,811 | -181,702 |
| Other shareholders' equity | 245 | 164 |
| TOTAL | $323,127 | $-173,396 |
| Total Liabilities And Equity | $358,234 | $25,924 |